AbstractUse of CCR5 antagonists requires previous viral tropism determination. The available methods have high cost, are time-consuming, or require highly trained personnel, and sophisticated equipment. We compared a flow cytometry-based tropism assay with geno2pheno method to determine HIV-1 tropism in AIDS patients, in Bahia, Brazil. We tested peripheral blood mononuclear cells of 102 AIDS patients under antiretroviral therapy by using a cytometry-based tropism assay and geno2pheno assay. Cellular membrane receptors were identified by using CXCR4, CCR5 and CD4 monoclonal antibodies, while detection of cytoplasmic mRNAs for gag and pol HIV regions was achieved by using a labeled probe. Genotypic identification of X4 and R5 tropic viruses w...
Determination of HIV-1 tropism is a pre-requisite to the use of CCR5 antagonists. This study evaluat...
BACKGROUND: Determination of HIV-1 tropism is a pre-requisite to the use of CCR5 antagonists. This s...
The possibility of performing genotypic tropism testing (GTT) with proviral DNA (pvDNA) even during ...
AbstractUse of CCR5 antagonists requires previous viral tropism determination. The available methods...
BackgroundHIV-1 coreceptor tropism testing is used to evaluate eligibility for CCR5 antagonist thera...
We developed a sequencing assay for genotypic HIV-1 tropism determination. The assay allows examinat...
The clinical application of CCR5 antagonists involves first determining the coreceptor usage by the ...
CCR5 antagonists are a powerful new class of antiretroviral drugs that require a companion assay to ...
Objectives: Although founder viruses in primary HIV-1 infections (PHIs) typically use the CCR5 corec...
BACKGROUND: Trofile is the prospectively validated HIV-1 tropism assay. Its use is limited by high ...
BACKGROUND: Trofile is the prospectively validated HIV-1 tropism assay. Its use is limited by high c...
BackgroundAn HIV-1 tropism test is recommended prior to CCR5 antagonist administration to exclude pa...
HIV-1 coreceptor tropism assays are required to rule out the presence of CXCR4-tropic (non-R5) virus...
HIV-1 coreceptor tropism assays are required to rule out the presence of CXCR4-tropic (non-R5) virus...
A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected individu...
Determination of HIV-1 tropism is a pre-requisite to the use of CCR5 antagonists. This study evaluat...
BACKGROUND: Determination of HIV-1 tropism is a pre-requisite to the use of CCR5 antagonists. This s...
The possibility of performing genotypic tropism testing (GTT) with proviral DNA (pvDNA) even during ...
AbstractUse of CCR5 antagonists requires previous viral tropism determination. The available methods...
BackgroundHIV-1 coreceptor tropism testing is used to evaluate eligibility for CCR5 antagonist thera...
We developed a sequencing assay for genotypic HIV-1 tropism determination. The assay allows examinat...
The clinical application of CCR5 antagonists involves first determining the coreceptor usage by the ...
CCR5 antagonists are a powerful new class of antiretroviral drugs that require a companion assay to ...
Objectives: Although founder viruses in primary HIV-1 infections (PHIs) typically use the CCR5 corec...
BACKGROUND: Trofile is the prospectively validated HIV-1 tropism assay. Its use is limited by high ...
BACKGROUND: Trofile is the prospectively validated HIV-1 tropism assay. Its use is limited by high c...
BackgroundAn HIV-1 tropism test is recommended prior to CCR5 antagonist administration to exclude pa...
HIV-1 coreceptor tropism assays are required to rule out the presence of CXCR4-tropic (non-R5) virus...
HIV-1 coreceptor tropism assays are required to rule out the presence of CXCR4-tropic (non-R5) virus...
A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected individu...
Determination of HIV-1 tropism is a pre-requisite to the use of CCR5 antagonists. This study evaluat...
BACKGROUND: Determination of HIV-1 tropism is a pre-requisite to the use of CCR5 antagonists. This s...
The possibility of performing genotypic tropism testing (GTT) with proviral DNA (pvDNA) even during ...